{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T13:18:42Z","timestamp":1770988722174,"version":"3.50.1"},"reference-count":25,"publisher":"Oxford University Press (OUP)","issue":"9","license":[{"start":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T00:00:00Z","timestamp":1653091200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100010463","name":"Institut Curie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010463","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,11,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objectives<\/jats:title>\n                  <jats:p>The risk of chronic exposure to antineoplastic agents in hospitals, mainly by skin contact with contaminated surfaces, is well established. The aim of this study was to assess indirectly the risk of occupational exposure to antineoplastics drugs at two hospitals by using an environmental monitoring, and to suggest ways of improving the exposure to healthcare workers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>An observational study of care practices on both sites was carried out. A wipe sampling campaign was then designed to study environmental contamination throughout the chemotherapy process: receipt, storage, compounding, transport, administration, and elimination areas. Samples were analyzed by a validated LC-MS\/MS method allowing trace quantification of cyclophosphamide. A guidance \u2018safe value\u2019 of 0.10 ng\/cm2 was considered.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>A total of 293 samples were analyzed, of which 58% were found to be positive. In the compounding units, the drug vials were contaminated before [range = (non-quantifiable [NQ]-0.71) ng\/cm2] and after cleaning procedure [(NQ-0.62) ng\/cm2], particularly when the flip-off lid was removed during cleaning. The contamination found on manual preparations was operator-dependent: [non-detectable (ND)-3.51] ng\/cm2 on infusion bag surfaces; (780.61\u201324 698.98) ng\/cm2 on medication ports. In the case of automated preparations, the average contamination was higher on infusion bag surfaces [(2.43\u201336.86) ng\/cm2] and lower on medication ports [(0.43\u20137.65) ng\/cm2] than manual preparations. Contamination of the analytical control area was also highlighted. In the daily care unit, the contamination was located near the infusion area (armchairs, infusion stands, floor, and patient toilets), and varied somewhat between the two sites, especially on the floor with (0.46\u201327.32) compared to (ND-0.18) ng\/cm2. We did not detect contamination on the transport boxes, on the door handles or in the disposal areas.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>The variability of contamination observed between the two sites can be explained in part by the difference in routine practices, especially training of the staff, and cleaning procedures. Findings were communicated to healthcare workers, and news interventions were implemented based on wipe sampling results. This study demonstrated a method for routine environmental monitoring and worker education as a strategy to reduce occupational exposure.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/annweh\/wxac035","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T11:30:20Z","timestamp":1651145420000},"page":"1215-1223","source":"Crossref","is-referenced-by-count":11,"title":["Application of an Environmental Monitoring to Assess the Practices and Control the Risk of Occupational Exposure to Cyclophosphamide in Two Sites of a French Comprehensive Cancer Center"],"prefix":"10.1093","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7793-7374","authenticated-orcid":false,"given":"Alexandre","family":"Acramel","sequence":"first","affiliation":[{"name":"Institut Curie, PSL Research University, D\u00e9partement de Pharmacie , F-75005, Paris , France"},{"name":"Universit\u00e9 de Paris, CiTCoM, UMR 8038 CNRS, U 1268 INSERM , F-75006, Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9914-8819","authenticated-orcid":false,"given":"Julien","family":"Fouque","sequence":"additional","affiliation":[{"name":"Institut Curie, D\u00e9partement de Radio-Pharmacologie , F-92210, Saint-Cloud , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6437-8753","authenticated-orcid":false,"given":"Sandy","family":"Blondeel-Gomes","sequence":"additional","affiliation":[{"name":"Institut Curie, PSL Research University, D\u00e9partement de Radio-Pharmacologie , F-75005, Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6403-9110","authenticated-orcid":false,"given":"Samuel","family":"Huguet","sequence":"additional","affiliation":[{"name":"Institut Curie, D\u00e9partement de Radio-Pharmacologie , F-92210, Saint-Cloud , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3328-3102","authenticated-orcid":false,"given":"Keyvan","family":"Rezai","sequence":"additional","affiliation":[{"name":"Institut Curie, D\u00e9partement de Radio-Pharmacologie , F-92210, Saint-Cloud , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1374-0879","authenticated-orcid":false,"given":"Olivier","family":"Madar","sequence":"additional","affiliation":[{"name":"Institut Curie, D\u00e9partement de Radio-Pharmacologie , F-92210, Saint-Cloud , France"},{"name":"Institut Curie, PSL Research University, D\u00e9partement de Radio-Pharmacologie , F-75005, Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3093-339X","authenticated-orcid":false,"given":"Laurence","family":"Escalup","sequence":"additional","affiliation":[{"name":"Institut Curie, PSL Research University, D\u00e9partement de Pharmacie , F-75005, Paris , France"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,5,21]]},"reference":[{"key":"2022111508584723200_CIT0001","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1080\/15459624.2014.916809","article-title":"Adherence to safe handling guidelines by health care workers who administer antineoplastic drugs","volume":"11","author":"Boiano","year":"2014","journal-title":"J Occup Environ Hyg"},{"key":"2022111508584723200_CIT0002","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1177\/1078155211402106","article-title":"Pilot assessment of the antineoplastic drug contamination levels in British Columbian hospitals pre- and post-cleaning","volume":"18","author":"Chu","year":"2012","journal-title":"J Oncol Pharm Pract"},{"key":"2022111508584723200_CIT0003","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/ajhp\/56.14.1427","article-title":"Surface contamination with antineoplastic agents in six cancer treatment centers in Canada and the United States","volume":"56","author":"Connor","year":"1999","journal-title":"Am J Health Syst Pharm"},{"key":"2022111508584723200_CIT0004","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/ajhp\/62.5.475","article-title":"Surface contamination of chemotherapy drug vials and evaluation of new vial-cleaning techniques: results of three studies","volume":"62","author":"Connor","year":"2005","journal-title":"Am J Health Syst Pharm"},{"key":"2022111508584723200_CIT0005","first-page":"619","article-title":"Environmental contamination with cytotoxic drugs in healthcare using positive air pressure isolators","volume":"49","author":"Crauste-Manciet","year":"2005","journal-title":"Ann Occup Hyg"},{"key":"2022111508584723200_CIT0006","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1177\/1078155217704990","article-title":"Carry-over of antineoplastic drug contamination in Dutch hospital pharmacies","volume":"24","author":"Crul","year":"2018","journal-title":"J Oncol Pharm Pract"},{"key":"2022111508584723200_CIT0007","article-title":"Guideline on bioanalytical method validation","author":"European Medicines Agency (EMA), Committee for Medical Products for Human Use (CHMP; 2011)"},{"key":"2022111508584723200_CIT0008","article-title":"Barriers and facilitators for the safe handling of antineoplastic drugs","author":"Fazel","year":"2021","journal-title":"J Oncol Pharm Pract"},{"key":"2022111508584723200_CIT0009","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1039\/c2em10704j","article-title":"Hygienic guidance values for wipe sampling of antineoplastic drugs in Swedish hospitals","volume":"14","author":"Hedmer","year":"2012","journal-title":"J Environ Monit"},{"key":"2022111508584723200_CIT0010","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/ejhpharm-2018-001705","article-title":"External contamination of commercial containers by antineoplastic agents: a literature review","volume":"27","author":"Hilliquin","year":"2020","journal-title":"Eur J Hosp Pharm"},{"key":"2022111508584723200_CIT0011","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/15459624.2016.1237026","article-title":"A review of surface wipe sampling compared to biologic monitoring for occupational exposure to antineoplastic drugs","volume":"14","author":"Kibby","year":"2017","journal-title":"J Occup Environ Hyg"},{"key":"2022111508584723200_CIT0012","first-page":"444","article-title":"Application and assessment of a regular environmental monitoring of the antineoplastic drug contamination level in pharmacies\u2015the MEWIP project","volume":"57","author":"Kiffmeyer","year":"2013","journal-title":"Ann Occup Hyg"},{"key":"2022111508584723200_CIT0013","first-page":"604","article-title":"Evidence of exposure to cytostatic drugs in healthcare staff: a review of recent literature","volume":"40","author":"Mart\u00edn Lancharro","year":"2016","journal-title":"Farm Hosp"},{"key":"2022111508584723200_CIT0014","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jchromb.2017.06.028","article-title":"A review of high performance liquid chromatographic-mass spectrometric urinary methods for anticancer drug exposure of health care workers","volume":"1060","author":"Mathias","year":"2017","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"2022111508584723200_CIT0015","article-title":"NIOSH Alert: Preventing occupational exposures to antineoplastic and other hazardous drugs in health care settings","author":"NIOSH","year":"2004","journal-title":"Centers for Disease Control and Prevention"},{"key":"2022111508584723200_CIT0016","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1016\/j.talanta.2011.08.034","article-title":"Analysis of anticancer drugs: a review","volume":"85","author":"Nussbaumer","year":"2011","journal-title":"Talanta"},{"key":"2022111508584723200_CIT0017","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3390\/ph14060574","article-title":"Cytostatics in indoor environment: an update of analytical methods","volume":"14","author":"Portilha-Cunha","year":"2021","journal-title":"Pharmaceuticals (Basel)"},{"key":"2022111508584723200_CIT0018","first-page":"703","article-title":"Guidance values for surface monitoring of antineoplastic drugs in German pharmacies","volume":"53","author":"Schierl","year":"2009","journal-title":"Ann Occup Hyg"},{"key":"2022111508584723200_CIT0019","first-page":"3","article-title":"Environmental contamination with cytostatic drugs: past, present and future","volume":"Special Edition, Fall","author":"Sessink","year":"2011","journal-title":"Saf Consid Oncol Pharm"},{"key":"2022111508584723200_CIT0020","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1310\/hpj4803-204","article-title":"Reduction in surface contamination with cyclophosphamide in 30 US hospital pharmacies following implementation of a closed-system drug transfer device","volume":"48","author":"Sessink","year":"2013","journal-title":"Hosp Pharm"},{"key":"2022111508584723200_CIT0021","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1177\/1078155219831427","article-title":"Efficiency of degradation or desorption methods in antineoplastic drug decontamination: a critical review","volume":"25","author":"Simon","year":"2019","journal-title":"J Oncol Pharm Pract"},{"key":"2022111508584723200_CIT0022","first-page":"765","article-title":"Cyclophosphamide contamination observed on the external surfaces of drug vials and the efficacy of cleaning on vial contamination","volume":"52","author":"Touzin","year":"2008","journal-title":"Ann Occup Hyg"},{"key":"2022111508584723200_CIT0025","first-page":"649","article-title":"Residual hazard assessment related to handling of antineoplastic drugs: safety system evolution and quality assurance of analytical measurement","volume-title":"Ann N Y Acad Sci","author":"Turci","year":"2006"},{"key":"2022111508584723200_CIT0023","article-title":"USP General Chapter &lt;800&gt; Hazardous Drugs\u2013Handling in Healthcare Settings","author":"United States Pharmacopeia (USP)","year":"2019"},{"key":"2022111508584723200_CIT0024","doi-asserted-by":"crossref","first-page":"7807","DOI":"10.1007\/s10661-014-3969-1","article-title":"Antineoplastic drugs contamination of workplace surfaces in two Portuguese hospitals","volume":"186","author":"Viegas","year":"2014","journal-title":"Environ Monit Assess"}],"container-title":["Annals of Work Exposures and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/annweh\/article-pdf\/66\/9\/1215\/46954964\/wxac035.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/annweh\/article-pdf\/66\/9\/1215\/46954964\/wxac035.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T08:59:03Z","timestamp":1668502743000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/annweh\/article\/66\/9\/1215\/6590293"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,21]]},"references-count":25,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,5,21]]},"published-print":{"date-parts":[[2022,11,15]]}},"URL":"https:\/\/doi.org\/10.1093\/annweh\/wxac035","relation":{},"ISSN":["2398-7308","2398-7316"],"issn-type":[{"value":"2398-7308","type":"print"},{"value":"2398-7316","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,11,1]]},"published":{"date-parts":[[2022,5,21]]}}}